Recent ED use, regardless of cause, is an important risk factor for IBD-related ED use in pediatric patients. The first several months after diagnosis constitute a particularly high-risk time for ED use.
Resnick et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: